Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shut down

With little fanfare, Anthony Letai, a highly respected physician-scientist, was sworn in as the 18th director of the National Cancer Institute on Sept. 29. Then, two days later, on Oct. 1, the government shut down.

October 01, 2025

Guest Editorial

Population-based cancer surveillance is a national treasure at risk

There is a silent crisis in cancer research that underpins nearly all aspects of the work we do to combat this disease.

September 26, 2025

Vol.51 No.35

By Eric B. Durbin, Karen L. Knight, Betsy Kohler and Sarah Nash

Cancer Policy

Bhattacharya: New grant review criterion is “not political”

NIH’s new “unified grant funding policy,” is “not political,” NIH Director Jay Bhattacharya said during his remarks at Research!America’s annual National Health Research Forum Sept. 17.

September 26, 2025

Vol.51 No.35

By Jacquelyn Cobb

Funding Opportunities

Project Purple announces research grant to sustain pancreatic cancer studies that have been disrupted by federal funding policy changes

Project Purple, a national nonprofit dedicated to empowering the fight against pancreatic cancer, is launching the Pancreatic Cancer Research Recovery Support Grant. The initiative provides up to two years of bridge or rescue funding for promising pancreatic cancer research projects that were disrupted due to administrative funding policy changes at major federal agencies such as the NIH, the Department of Defense, or the National Science Foundation.

September 26, 2025

Vol.51 No.35

NCI

Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say

Anthony G. Letai, a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute whose research is focused on apoptosis and functional diagnostics, has been tapped by the Trump administration to become the 18th director of the National Cancer Institute.

September 25, 2025

Vol.51 No.35

By Claire Marie Porter and Paul Goldberg

Podcast

Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes.

With the fiscal year drawing to a close, grant funding from NCI is picking up speed, offering a glimmer of hope to cancer researchers who are beginning to feel cautiously optimistic about the road ahead.

September 24, 2025

Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

YOU MAY BE INTERESTED IN

With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shut down

Population-based cancer surveillance is a national treasure at risk

Bhattacharya: New grant review criterion is “not political”

Project Purple announces research grant to sustain pancreatic cancer studies that have been disrupted by federal funding policy changes

Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say

Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes.

Renew today!

Subscriber content

Never miss an issue!

Login

Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

YOU MAY BE INTERESTED IN

With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shut down

Population-based cancer surveillance is a national treasure at risk

Bhattacharya: New grant review criterion is “not political”

Project Purple announces research grant to sustain pancreatic cancer studies that have been disrupted by federal funding policy changes

Anthony G. Letai to be named NCI directorThe Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say

Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes.

Never miss an issue!

Login

Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say